Evicenter
Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) in Chronic obstructive pulmonary disease
Manufacturer
GlaxoSmithKline
Questions
32
Last updated

All questions

Real-world evidence: Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) in chronic obstructive pulmonary disease

2 questions · 1 source

Real-world evidence

Is an early Trelegy start after a first COPD exacerbation linked to fewer exacerbations?

Note: Early initiation was 0 to 30 days and delayed initiation 31 to 180 days after the first exacerbation.

Is an early Trelegy start linked to a later next COPD exacerbation?